Astrana Health (ASTH) Revenue & Revenue Breakdown
Astrana Health Revenue Highlights
Latest Revenue (Y)
$2.03B
Latest Revenue (Q)
$620.39M
Main Segment (Y)
Health Care Capitation Revenue
Astrana Health Revenue by Period
Astrana Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $2.03B | 46.72% |
| 2023-12-31 | $1.39B | 21.19% |
| 2022-12-31 | $1.14B | 47.84% |
| 2021-12-31 | $773.91M | 109.03% |
| 2020-12-31 | $370.25M | -33.96% |
| 2019-12-31 | $560.62M | 7.83% |
| 2018-12-31 | $519.91M | 45.33% |
| 2017-12-31 | $357.75M | 712.16% |
| 2016-03-31 | $44.05M | - |
Astrana Health generated $2.03B in revenue during NA 2024, up 46.72% compared to the previous quarter, and up 362.91% compared to the same period a year ago.
Astrana Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $620.39M | -6.74% |
| 2024-12-31 | $665.21M | 38.96% |
| 2024-09-30 | $478.71M | -1.55% |
| 2024-06-30 | $486.26M | 20.26% |
| 2024-03-31 | $404.36M | 14.54% |
| 2023-12-31 | $353.04M | 1.40% |
| 2023-09-30 | $348.17M | -0.01% |
| 2023-06-30 | $348.21M | 3.25% |
| 2023-03-31 | $337.24M | 14.63% |
| 2022-12-31 | $294.21M | -7.19% |
| 2022-09-30 | $317.00M | 17.54% |
| 2022-06-30 | $269.70M | 2.45% |
| 2022-03-31 | $263.26M | 34.93% |
| 2021-12-31 | $195.10M | -14.10% |
| 2021-09-30 | $227.12M | 29.31% |
| 2021-06-30 | $175.64M | - |
Astrana Health generated $620.39M in revenue during Q1 2025, up -6.74% compared to the previous quarter, and up 175.73% compared to the same period a year ago.
Astrana Health Revenue Breakdown
Astrana Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 |
|---|---|
| Product and Service, Other | $15.22M |
| Health Care, Patient Service | $62.33M |
| Health Care, Other | $86.22M |
| Health Care Capitation Revenue | $1.86B |
| Management Service | $13.98M |
Astrana Health's latest annual revenue breakdown by segment (product or service), as of Dec 24: Health Care Capitation Revenue (91.26%), Health Care, Other (4.24%), Health Care, Patient Service (3.06%), Product and Service, Other (0.75%), and Management Service (0.69%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 |
|---|---|---|---|---|---|
| Product and Service, Other | $4.84M | $4.74M | $7.41M | $4.09M | $3.72M |
| Health Care Capitation Revenue | $614.11M | $583.96M | $982.81M | $431.40M | $442.57M |
| Health Care, Other | $15.40M | $14.49M | $46.04M | $21.78M | $18.41M |
| Health Care, Patient Service | $17.88M | $14.89M | $23.68M | $18.69M | $19.96M |
| Management Service | $2.58M | $2.31M | $9.63M | $2.75M | $1.60M |
Astrana Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Health Care Capitation Revenue (93.78%), Health Care, Patient Service (2.73%), Health Care, Other (2.35%), Product and Service, Other (0.74%), and Management Service (0.39%).
Astrana Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SEM | Select Medical | $5.19B | $1.34B |
| ASTH | Astrana Health | $2.03B | $620.39M |
| MD | Pediatrix Medical Group | $2.01B | $468.84M |
| CLOV | Clover Health Investments | $1.37B | $477.62M |
| PAHC | Phibro Animal Health | $1.30B | $309.26M |
| OMCL | Omnicell | $1.11B | $290.56M |
| GDRX | GoodRx | $792.32M | $202.97M |
| NVCR | NovoCure | $605.22M | $154.99M |
| USPH | U.S. Physical Therapy | $560.55M | $164.18M |
| UFPT | UFP | $504.42M | $151.18M |
| AUPH | Aurinia Pharmaceuticals | $235.13M | $70.01M |